Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,657 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.
Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, Pavkov ME, Rolka DB, Wiltz JL, Bull-Otterson L, Gray S, Boehmer TK, Gundlapalli AV, Siegel DA, Kompaniyets L, Goodman AB, Mahon BE, Tauxe RV, Remley K, Saydah S. Barrett CE, et al. Among authors: goodman ab. MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65. doi: 10.15585/mmwr.mm7102e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35025851 Free PMC article.
Star formation near the Sun is driven by expansion of the Local Bubble.
Zucker C, Goodman AA, Alves J, Bialy S, Foley M, Speagle JS, Groβschedl J, Finkbeiner DP, Burkert A, Khimey D, Swiggum C. Zucker C, et al. Among authors: goodman aa. Nature. 2022 Jan;601(7893):334-337. doi: 10.1038/s41586-021-04286-5. Epub 2022 Jan 12. Nature. 2022. PMID: 35022612
Antibiotics prior to age 2 years have limited association with preschool growth trajectory.
Bailey LC, Bryan M, Maltenfort M, Block JP, Teneralli R, Lunsford D, Boone-Heinonen J, Eneli I, Horgan CE, Lin PD, Reynolds JS, Solomonides AE, Janicke D, Sturtevant JL, Toh S, Taveras E, Appelhans BM, Arterburn D, Daley MF, Dempsey A, Dugas LR, Finkelstein J, Fitzpatrick SL, Goodman A, Gurka MJ, Heerman WJ, Horberg M, Hossain MJ, Hsia DS, Isasi CR, Kharbanda EO, Messito MJ, Murphy K, O'Bryan K, Peay HL, Prochaska MT, Puro J, Rayas M, Rosenman MB, Taylor B, VanWormer JJ, Willis Z, Yeramaneni S, Forrest CB; PCORnet Antibiotics and Childhood Growth Study Group. Bailey LC, et al. Among authors: goodman a. Int J Obes (Lond). 2022 Jan 8. doi: 10.1038/s41366-021-01023-w. Online ahead of print. Int J Obes (Lond). 2022. PMID: 34999718
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
Turkova A, White E, Mujuru HA, Kekitiinwa AR, Kityo CM, Violari A, Lugemwa A, Cressey TR, Musoke P, Variava E, Cotton MF, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch SB, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe GM, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb DM; ODYSSEY Trial Team. Turkova A, et al. N Engl J Med. 2021 Dec 30;385(27):2531-2543. doi: 10.1056/NEJMoa2108793. N Engl J Med. 2021. PMID: 34965338 Clinical Trial.
1,657 results